Table 8.
Number of countries with significantly increasing or decreasing trends in resistance to selected antimicrobials for Campylobacter jejuni and C. coli from humans, 2016–2020, broilers, 2009–2020, fattening turkeys 2014–2020 and pigs, 2009–2020
| Species | Ciprofloxacin | Erythromycin | Tetracycline | ||||
|---|---|---|---|---|---|---|---|
| Incr. | Decr. | Incr. | Decr. | Incr. | Decr. | ||
| Humans | C. jejuni (16 MS + 3 non‐MS) | 9 (DK, ES, FR, LT, MT, NL, SI, SK, UK) | 4 (EE, FI, NO, PT) | – | 5 (FI, LT, MT, NO, UK) | 4 (DK, NL, SK, UK) | 6 (CY, EE, FI, LT, NO, PT) |
| C. coli (14 MSs+1 non‐MS) | 1 (SI) | 4 (FR, LU, PT, UK) | 2 (FI, NL) | 2 (EE, SK) | – | – | |
| Broilers |
C. jejuni (24 MS + 4 non‐MS) |
14 (AT, DE, HR, CY, CZ, DK, FI, FR, NL, RO, SE, SK, CH, UK) |
1 (ES) |
– |
6 (BG, HU, NL, RO, SK, ES) |
11 (AT, HR, CZ, DK, DE, IE, LT, SK, SE, CH, UK) |
7 (BG, CY, FI, EL, IT, LV, ES) |
|
C. coli (8 MS, 1 non‐MS) |
3 (HR, DE, NL) |
1 (FR) |
1 (CZ) |
3 (AT, FR, NL) |
4 (CZ, DE, HR, CH) |
– | |
| Turkeys |
C. jejuni (8 MS, 1 non‐MS) |
2 (DE, PL) |
2 (HU, IT) |
3 (DE, PL, ES) |
1 (HU) |
4 (DE, ES, FR, UK) |
|
| Pigs |
C. coli (7 MS + 2 non‐MS) |
3 (DE, NO, CH) | 4 (HR, ES, NL, CH) | 1 (CH) | 1 (HR) | ||